Brainstorm Cell Therapeutics Inc (BCLI)
NASDAQ
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -35.783 | -44.635 | -123.156 | -261.829 | -110.086 | -60.736 | -128.695 | -271.617 |
Return on Equity (%) | -41.465 | -62.755 | -256.021 | 645.289 | -273.749 | -89.249 | -297.385 | 436.733 |
Return on Invested Capital (%) | -42.387 | -69.677 | -306.35 | 609.621 | -273.032 | -89.593 | -304.995 | 529.162 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.53 | 0.31 | 0.242 | -0.527 | 1.009 | 0.531 | -0.082 | -0.099 |
Earnings Per Share | -0.267 | -0.261 | -0.672 | -1.003 | -0.905 | -0.672 | -0.662 | -0.351 |
Cash Per Share | 0.029 | 0.131 | 0.045 | 0.023 | 1.076 | 0.518 | 0.021 | 0.027 |
Working Capital Per Share | 0.513 | 0.215 | 0.195 | -0.617 | 0.911 | 0.466 | -0.155 | -0.12 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.267 | -0.261 | -0.672 | -1.003 | -0.905 | -0.672 | -0.662 | -0.351 |
EBITDA Per Share | -0.267 | -0.261 | -0.672 | -1.003 | -0.905 | -0.672 | -0.662 | -0.351 |
Free Cash Flow Per Share | -0.265 | -0.256 | -0.659 | -0.99 | -0.9 | -0.67 | -0.669 | -0.356 |
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Year End December 30 2023 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Shares Outstanding | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 11.92M |
Price to Earnings Ratio | 0 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 5.7M |
Average Volume (1 week) | 52.96k |
Average Volume (1 Month) | 120.42k |
52 Week Change | -59.80% |
52 Week High | 11.8905 |
52 Week Low | 1.05 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.